Cue Biopharma, Inc. Made Big Gain
Wed, Apr 15, 2026 at 07:20 PM
Cue Biopharma, Inc. (CUE:NASDAQ) soared at $0.72, representing a gain of 65.4%. On Wed, Apr 15, 2026, CUE:NASDAQ touched a New 2-Week High of $0.72. The stock appeared on our News Catalysts scanner on Wed, Apr 15, 2026 at 10:19 AM in the 'BIOTECH' category. From Wed, Apr 01, 2026, the stock recorded 55.56% Up Days and 60.00% Green Days
About Cue Biopharma, Inc. (CUE:NASDAQ)
Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Top 10 Gainers:
- Smart for Life, Inc. (SMFL:NASDAQ), 1100%
- Allbirds, Inc. (BIRD:NASDAQ), 582.33%
- HUB Cyber Security Ltd. (HUBC:NASDAQ), 104.72%
- Immutep Limited (IMMP:NASDAQ), 72.81%
- Xanadu Quantum Technologies Limited (XNDU:NASDAQ), 69.79%
- XChange TEC.INC (XHG:NASDAQ), 69.78%
- Cue Biopharma, Inc. (CUE:NASDAQ), 65.37%
- Inotiv, Inc. (NOTV:NASDAQ), 59.02%
- Society Pass Incorporated (SOPA:NASDAQ), 55.14%
- Skillz Inc. (SKLZ:NYSE), 53.57%